KLK3 and Familial prostate cancer: Furthermore, there is no previously reported evidence describing the classifying of different diagnoses regarding prostate cancer and prostatitis or prostatosis in addition to the conventional method, i.e., PSA, while in the current study, there is an enhanced performance when adding identified EV proteins to the conventional model with age, BMI, prostate size, and PSA.